Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) [Phase 1]
Phase 1 study update on 131I-TLX-101 for newly diagnosed glioblastoma; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma [Phase 1]
A Phase 1 study evaluating the combination of low-intensity focused ultrasound with immunotherapy for newly diagnosed unmethylated glioblast…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN). [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating PLB1001 enteric capsules for IDH-mutant glioblastoma with ZM fusion in glioblastoma patients; the stud…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Key Longitudinal Associations With Risk and Glioblastoma Outcomes
The document provides an update on a recruiting clinical trial studying longitudinal associations with risk and outcomes in glioblastoma, sp…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors [NA]
This ClinicalTrials.gov entry describes a study testing a customized neuro-imaging referenced symptom video intended to reduce patient and c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors [Phase 1]
Clinical trial update indicating that Loc3CAR (B7-H3-CAR T cells) delivery is in early-phase pediatric CNS tumor trials and currently recrui…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy [NA]
This clinical trial update describes a study evaluating biomarkers that predict 6-month survival for glioblastoma patients at first relapse …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Control Cohort CTRL COH [NA]
A status update for a control cohort in a Hospices Civils de Lyon trial, with recruitment ongoing for Parkinson's disease, amyotrophic later…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma [Phase 2]
Phase 2 clinical trial evaluating Gallium-68 PSMA-11 PET/CT for detecting recurrence or progression in high-grade gliomas (WHO Grade 3 and G…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas [Phase 2]
A Phase 2 clinical trial from MD Anderson is evaluating chemotherapy and radiation therapy for IDH-wildtype gliomas and non-histological (mo…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM [Phase 2]
BIO-SHORT is a Phase 2 trial evaluating biologically guided short-course hypofractionated radiotherapy for poorly prognostic glioblastoma. T…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]
Phase 2 trial comparing dose-escalated photon IMRT or proton beam radiation therapy with standard-dose radiation therapy plus temozolomide i…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Antisecretory Factor Glioblastoma Phase 2 [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating antisecretory factor for glioblastoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab [Phase 2]
A Phase 2 trial evaluating the combination of nivolumab and relatlimab for newly diagnosed glioblastoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer [Phase 1]
A Phase 1 trial evaluating the safety of a chemo-immunotherapy combo of ibrutinib and indoximod in pediatric brain tumor patients, including…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma [Phase 1]
Phase 1 trial evaluating Carmustine wafer in combination with Retifanlimab and radiation, with or without temozolomide, in glioblastoma.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial [Phase 2]
A Phase 2 randomized trial assessing the combination of OPTune GIO (tumor treating fields device) with MRI-guided laser ablation and pembrol…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Natural Progesterone for the Treatment of Recurrent Glioblastoma [EARLY_Phase 1]
A Phase 1 study of natural progesterone for recurrent glioblastoma and gliosarcoma is being conducted by Emory University, with status liste…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
This clinical trial update describes the CCANED-CIPHER study, an ongoing investigation using AI-based transcriptomic profiling of platelets …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Newly Diagnosed Glioblastoma [Phase 2]
A Phase 2 clinical trial for newly diagnosed Glioblastoma is active but not recruiting, sponsored by Sun Yat-sen University.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma [Phase 1, Phase 2]
This entry describes an ongoing Phase 1/2 clinical trial evaluating VRT106 for injection in patients with recurrent or progressive glioblast…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]
A Phase 2 clinical trial evaluating WP1066 with radiation therapy for newly diagnosed glioblastoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma [Phase 1]
This update describes a Phase I clinical trial of an mRNA vaccine for recurrent or progressive high-grade glioma that is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma [Phase 1]
This clinical trial update reports on a novel gamma-delta (γδ) T cell therapy being studied for newly diagnosed glioblastoma in adults; the …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma [Phase 2]
This is a Phase 2 trial evaluating the addition of ruxolitinib to radiation and temozolomide for newly diagnosed glioblastoma. The study is …